AU2001293948A1 - Cyclic peptides, method for preparing same and use as angiogenesis inhibitor or activator - Google Patents

Cyclic peptides, method for preparing same and use as angiogenesis inhibitor or activator

Info

Publication number
AU2001293948A1
AU2001293948A1 AU2001293948A AU2001293948A AU2001293948A1 AU 2001293948 A1 AU2001293948 A1 AU 2001293948A1 AU 2001293948 A AU2001293948 A AU 2001293948A AU 2001293948 A AU2001293948 A AU 2001293948A AU 2001293948 A1 AU2001293948 A1 AU 2001293948A1
Authority
AU
Australia
Prior art keywords
activator
angiogenesis inhibitor
cyclic peptides
preparing same
preparing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU2001293948A
Other versions
AU2001293948B2 (en
Inventor
Natacha Betz
Andreas Bikfalvi
Gerard Deleris
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Universite Victor Segalen Bordeaux 2
Universite des Sciences et Tech (Bordeaux 1)
Commissariat a lEnergie Atomique et aux Energies Alternatives CEA
Original Assignee
Universite Victor Segalen Bordeaux 2
Commissariat a lEnergie Atomique CEA
Universite des Sciences et Tech (Bordeaux 1)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR0012654A external-priority patent/FR2814744B1/en
Application filed by Universite Victor Segalen Bordeaux 2, Commissariat a lEnergie Atomique CEA, Universite des Sciences et Tech (Bordeaux 1) filed Critical Universite Victor Segalen Bordeaux 2
Publication of AU2001293948A1 publication Critical patent/AU2001293948A1/en
Application granted granted Critical
Publication of AU2001293948B2 publication Critical patent/AU2001293948B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

AU2001293948A 2000-10-04 2001-10-02 Cyclic peptides, method for preparing same and use as angiogenesis inhibitor or activator Ceased AU2001293948B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0012654A FR2814744B1 (en) 2000-10-04 2000-10-04 CYCLOPEPTIDES, THEIR PREPARATION PROCESS AND THEIR USE AS ANGIOGENESIS INHIBITOR OR ACTIVATOR
FR0012654 2000-10-04
PCT/FR2001/003049 WO2002028895A2 (en) 2000-10-04 2001-10-02 Cyclic peptides, method for preparing same and use as angiogenesis inhibitor or activator

Publications (2)

Publication Number Publication Date
AU2001293948A1 true AU2001293948A1 (en) 2002-06-27
AU2001293948B2 AU2001293948B2 (en) 2005-11-03

Family

ID=8854977

Family Applications (2)

Application Number Title Priority Date Filing Date
AU2001293948A Ceased AU2001293948B2 (en) 2000-10-04 2001-10-02 Cyclic peptides, method for preparing same and use as angiogenesis inhibitor or activator
AU9394801A Pending AU9394801A (en) 2000-10-04 2001-10-02 Cyclic peptides, method for preparing same and use as angiogenesis inhibitor or activator

Family Applications After (1)

Application Number Title Priority Date Filing Date
AU9394801A Pending AU9394801A (en) 2000-10-04 2001-10-02 Cyclic peptides, method for preparing same and use as angiogenesis inhibitor or activator

Country Status (15)

Country Link
US (2) USRE44022E1 (en)
EP (1) EP1328546B1 (en)
JP (1) JP4303958B2 (en)
AT (1) ATE354589T1 (en)
AU (2) AU2001293948B2 (en)
CA (1) CA2424506A1 (en)
DE (1) DE60126802T2 (en)
DK (1) DK1328546T3 (en)
ES (1) ES2282293T3 (en)
FR (1) FR2814744B1 (en)
IL (1) IL155117A0 (en)
NO (1) NO20031377L (en)
NZ (1) NZ525069A (en)
RU (1) RU2249599C2 (en)
WO (1) WO2002028895A2 (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7211240B2 (en) * 2002-03-01 2007-05-01 Bracco International B.V. Multivalent constructs for therapeutic and diagnostic applications
US7794693B2 (en) * 2002-03-01 2010-09-14 Bracco International B.V. Targeting vector-phospholipid conjugates
CA2513044A1 (en) 2002-03-01 2004-08-05 Dyax Corp. Kdr and vegf/kdr binding peptides and their use in diagnosis and therapy
US7261876B2 (en) 2002-03-01 2007-08-28 Bracco International Bv Multivalent constructs for therapeutic and diagnostic applications
US8623822B2 (en) 2002-03-01 2014-01-07 Bracco Suisse Sa KDR and VEGF/KDR binding peptides and their use in diagnosis and therapy
US20050214859A1 (en) 2003-03-03 2005-09-29 Dyax Corp. Peptides that specifically bind HGF receptor (cMet) and uses thereof
WO2007082890A1 (en) * 2006-01-17 2007-07-26 N.V. Organon SELECTIVE ENZYMATIC HYDROLYSIS OF C-TERMINAL tert-BUTYL ESTERS OF PEPTIDES
EP2106404A2 (en) 2006-10-19 2009-10-07 Ramot at Tel Aviv University Ltd. Compositions and methods for inducing angiogenesis
EP2456784B1 (en) * 2009-07-24 2017-01-11 Advanced Accelerator Applications S.A. Compounds modulators of vegf activity and uses thereof
FR2969999B1 (en) 2011-01-03 2013-02-08 Commissariat Energie Atomique CONJUGATE, PROCESS FOR PREPARING THE SAME AND USES THEREOF
JP6758022B2 (en) * 2012-09-03 2020-09-23 国立大学法人 東京大学 Vascular endothelial cell growth factor receptor inhibitor peptide
CN103724290B (en) * 2013-11-15 2015-04-29 浙江大学 Cyclopeptide compound clavatustide A as well as producing strain, preparation method and application thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4310643A1 (en) * 1993-04-01 1994-10-06 Merck Patent Gmbh Cyclic adhesion inhibitors
US5939383A (en) * 1996-11-15 1999-08-17 Remacle; Jose Cyclic peptides bearing a tail designed for subsequent chemical coupling and process for preparing same
AU757554B2 (en) * 1998-02-11 2003-02-27 Bracco International B.V. Angiogenesis targeting molecules
AU776473C (en) * 1999-03-11 2005-04-14 Entremed, Inc Compositions and methods for treating cancer and hyperproliferative disorders

Similar Documents

Publication Publication Date Title
AU2002218140A1 (en) Beam-shaping method
AU2001266926A1 (en) Hemostatic compositions, devices and methods
AU2002210881A1 (en) Transdermal method
AU2001284149A1 (en) Aminoalkylbenzoyl-benzofuran or benzothiophene derivatives, method for preparing same and compositions containing same
AU2001251083A1 (en) Method for using 2-aryloxyalkylaminobenzoxazoles and 2-aryloxyalkylaminobenzothiazoles as h3 antagonists
AU2001293948A1 (en) Cyclic peptides, method for preparing same and use as angiogenesis inhibitor or activator
ZA200201275B (en) Cyclic peptide derivatives as inhibitors of integrin alphavbeta6.
AU3425700A (en) Non-ribosomal peptide synthetases, method for producing same and the use thereof
AU2001260774A1 (en) Bio-support and preparing method of the same
AU2001275085A1 (en) Methods, compounds and compositions for treating gout
AU2001276027A1 (en) Heteroaryl-beta-alanine derivatives as alpha 4 integrin inhibitors
AU2002244149A1 (en) Absorbent article, method and apparatus for preaparing same
AU2002216968A1 (en) Plasma fraction containing bikunin, method for the production thereof and use of the same
AU2001234616A1 (en) Vaccine composition, process and methods
MXPA03002875A (en) Vaccine composition and stabilisation method.
AU2001295672A1 (en) Vaccine composition and stabilisation method
AU2002210632A1 (en) Novel aminotriazolone compounds, method for preparing same and pharmaceutical compositions containing same
AU2001229463A1 (en) Pathogen-reducing systems, compositions, articles and methods employing ozone
AU2002227966A1 (en) Coniosetin and derivatives thereof, method for producing the same and use thereof
AU2796602A (en) Coniosetin and derivatives thereof, method for producing the same and use thereof
AU2002246585A1 (en) Plant promoters, and methods of use
AU2001242750A1 (en) Novel protein, process for producing the same and use thereof
AU2001292010A1 (en) Rare earth or gallium additive composition, methods for preparing same and use thereof as catalyst
AU6730001A (en) Component, method for production and use thereof
AU2002227952A1 (en) Klainetin and derivatives thereof, method for their production and the use of the same